Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
Hum Genomics ; 18(1): 74, 2024 Jul 02.
Artículo en Inglés | MEDLINE | ID: mdl-38956740

RESUMEN

BACKGROUND: Evidence has revealed a connection between cuproptosis and the inhibition of tumor angiogenesis. While the efficacy of a model based on cuproptosis-related genes (CRGs) in predicting the prognosis of peripheral organ tumors has been demonstrated, the impact of CRGs on the prognosis and the immunological landscape of gliomas remains unexplored. METHODS: We screened CRGs to construct a novel scoring tool and developed a prognostic model for gliomas within the various cohorts. Afterward, a comprehensive exploration of the relationship between the CRG risk signature and the immunological landscape of gliomas was undertaken from multiple perspectives. RESULTS: Five genes (NLRP3, ATP7B, SLC31A1, FDX1, and GCSH) were identified to build a CRG scoring system. The nomogram, based on CRG risk and other signatures, demonstrated a superior predictive performance (AUC of 0.89, 0.92, and 0.93 at 1, 2, and 3 years, respectively) in the training cohort. Furthermore, the CRG score was closely associated with various aspects of the immune landscape in gliomas, including immune cell infiltration, tumor mutations, tumor immune dysfunction and exclusion, immune checkpoints, cytotoxic T lymphocyte and immune exhaustion-related markers, as well as cancer signaling pathway biomarkers and cytokines. CONCLUSION: The CRG risk signature may serve as a robust biomarker for predicting the prognosis and the potential viability of immunotherapy responses. Moreover, the key candidate CRGs might be promising targets to explore the underlying biological background and novel therapeutic interventions in gliomas.


Asunto(s)
Biomarcadores de Tumor , Glioma , Microambiente Tumoral , Humanos , Glioma/genética , Glioma/inmunología , Glioma/patología , Microambiente Tumoral/genética , Microambiente Tumoral/inmunología , Pronóstico , Biomarcadores de Tumor/genética , Neoplasias Encefálicas/genética , Neoplasias Encefálicas/inmunología , Neoplasias Encefálicas/patología , Regulación Neoplásica de la Expresión Génica/genética , Nomogramas , Femenino , Masculino , Perfilación de la Expresión Génica , Persona de Mediana Edad
2.
BMC Cancer ; 24(1): 836, 2024 Jul 13.
Artículo en Inglés | MEDLINE | ID: mdl-39003457

RESUMEN

BACKGROUND: The clinical features of cerebellar high-grade gliomas (cHGGs) in adults have not been thoroughly explored. This large-scale, population-based study aimed to comprehensively outline these traits and construct a predictive model. METHODS: Patient records diagnosed with gliomas were collected from various cohorts and analyzed to compare the features of cHGGs and supratentorial HGGs (sHGGs). Cox regression analyses were employed to identify prognostic factors for overall survival and to develop a nomogram for predicting survival probabilities in patients with cHGGs. Multiple machine learning methods were applied to evaluate the efficacy of the predictive model. RESULTS: There were significant differences in prognosis, with SEER-cHGGs showing a median survival of 7.5 months and sHGGs 14.9 months (p < 0.001). Multivariate Cox regression analyses revealed that race, WHO grade, surgical procedures, radiotherapy, and chemotherapy were independent prognostic factors for cHGGs. Based on these factors, a nomogram was developed to predict 1-, 3-, and 5-year survival probabilities, with AUC of 0.860, 0.837, and 0.810, respectively. The model's accuracy was validated by machine learning approaches, demonstrating consistent predictive effectiveness. CONCLUSIONS: Adult cHGGs are distinguished by distinctive clinical features different from those of sHGGs and are associated with an inferior prognosis. Based on these risk factors affecting cHGGs prognosis, the nomogram prediction model serves as a crucial tool for clinical decision-making in patient care.


Asunto(s)
Neoplasias Cerebelosas , Glioma , Nomogramas , Humanos , Femenino , Masculino , Glioma/mortalidad , Glioma/patología , Glioma/terapia , Persona de Mediana Edad , Adulto , Pronóstico , Neoplasias Cerebelosas/mortalidad , Neoplasias Cerebelosas/patología , Neoplasias Cerebelosas/terapia , Clasificación del Tumor , Anciano , Aprendizaje Automático , Programa de VERF , Adulto Joven
3.
ISA Trans ; 146: 236-248, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-38182438

RESUMEN

This paper proposes a fractional-order time-varying sliding mode control method with predefined-time convergence for a class of arbitrary-order nonlinear control systems with compound disturbances. The method has global robustness and strongly predefined-time stability. All state errors of the system can converge to zero at a desired time, which can be set arbitrarily with a simple parameter. The strongly predefined-time convergence of the system is clearly demonstrated by the analytic expression of state error, which is obtained by solving fractional-order differential equations corresponding to the sliding mode function. The simulation results show that the proposed method still has good control performance in the presence of input saturation and external interference.

SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda